Associated Papers
Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation.
Gaebler C et al.
Nature, 2026
Stratified analyses refine association between TLR7 rare variants and severe COVID-19.
Boos J et al.
Hgg Advances, 2024
Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease.
Horowitz JE et al.
Nature Genetics, 2022
Genome-wide analysis in 756,646 individuals provides first genetic evidence that ACE2 expression influences COVID-19 risk and yields genetic risk scores predictive of severe disease.
Horowitz JE et al.
Medrxiv : the Preprint Server for Health Sciences, 2021
Genetic variability in COVID-19-related genes in the Brazilian population.
Secolin R et al.
Human Genome Variation, 2021
Structural integrity with functional plasticity: what type I IFN receptor polymorphisms reveal.
de Weerd NA et al.
Journal of Leukocyte Biology, 2020
Investigation of DNA repair-related SNPs underlying susceptibility to papillary thyroid carcinoma reveals MGMT as a novel candidate gene in Belarusian children exposed to radiation.
Lonjou C et al.
Bmc Cancer, 2017
Immune response genes receptors expression and polymorphisms in relation to multiple sclerosis susceptibility and response to INF-β therapy.
Karam RA et al.
Iubmb Life, 2016
Symptom clusters of pain, depressed mood, and fatigue in lung cancer: assessing the role of cytokine genes.
Reyes-Gibby CC et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer, 2013
The role of non-HLA single nucleotide polymorphisms in multiple sclerosis susceptibility.
Bahreini SA et al.
Journal of Neuroimmunology, 2010
Triangulation of the human, chimpanzee, and Neanderthal genome sequences identifies potentially compensated mutations.
Zhang G et al.
Human Mutation, 2010
Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer.
Hildebrandt MA et al.
Plos One, 2010
Role of inflammation gene polymorphisms on pain severity in lung cancer patients.
Reyes-Gibby CC et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2009
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.
Welzel TM et al.
Hepatology (baltimore, Md.), 2009
Cytokine and cytokine receptor single-nucleotide polymorphisms predict risk for non-small cell lung cancer among women.
Van Dyke AL et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2009
Cytokine SNPs: Comparison of allele frequencies by race and implications for future studies.
Van Dyke AL et al.
Cytokine, 2009
Association of IL-10 receptor 2 (IL10RB) SNP with systemic sclerosis.
Hikami K et al.
Biochemical and Biophysical Research Communications, 2008
Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition.
Yang H et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2008
Recent advances in genetic analysis of multiple sclerosis: genetic associations and therapeutic implications.
Niino M et al.
Expert Review of Neurotherapeutics, 2007
Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence.
Frodsham AJ et al.
Proceedings of the National Academy of Sciences of the United States of America, 2006
IFNAR1 and IFNAR2 polymorphisms confer susceptibility to multiple sclerosis but not to interferon-beta treatment response.
Leyva L et al.
Journal of Neuroimmunology, 2005
Interferon-alpha receptor-1 (IFNAR1) variants are associated with protection against cerebral malaria in the Gambia.
Aucan C et al.
Genes and Immunity, 2003